Value Plays: Analysts Highlight Undervalued Dividend Stocks Amid Market Volatility

As the S&P 500 declines by more than 3% this year, investors are increasingly pivoting toward high-yield dividend stocks to hedge against geopolitical uncertainty and economic headwinds. Market analysts have highlighted three specific companies—AbbVie, Novo Nordisk, and Verizon Communications—as undervalued assets that offer a combination of attractive payouts and modest forward valuations. AbbVie (ABBV) has seen its shares drop 10% this year, yet it maintains a 3.4% dividend yield. While its trailing P/E appears high due to acquisition costs, its forward P/E stands at 14. The company reported $61.2 billion in revenue and $20.1 billion in operating income last year, reflecting a 33% operating margin. Novo Nordisk (NVO) has experienced a 28% share price decline following a projected revenue drop of up to 13%. Despite this, the company maintains a strong 41% operating profit margin and trades at a forward P/E of 11, offering a 4.9% dividend yield. Verizon (VZ) stands out as the only pick in positive territory for 2026, with shares rising nearly 20%. It offers the highest yield of the group at 5.8%, supported by a payout ratio of approximately 50%, suggesting the dividend remains sustainable in the near term. These selections reflect a broader trend of 'flight to safety' as investors prioritize consistent cash flow and conservative valuations over aggressive growth in a volatile macroeconomic environment.